
Results
12
Companies which are more than 50% undervalued based on analyst price target.
12 companies
Daiichi Sankyo Company
Market Cap: JP¥4.9t
Manufactures and sells pharmaceutical products in Japan and internationally.
4568
JP¥2,717.00
7D
5.4%
1Y
-15.7%
GNI Group
Market Cap: JP¥171.4b
Engages in the research, development, manufacturing, and sale of pharmaceuticals and biomaterials in Japan, China, and the United States.
2160
JP¥2,605.00
7D
-6.7%
1Y
-16.1%
PeptiDream
Market Cap: JP¥131.4b
A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.
4587
JP¥1,022.50
7D
1.4%
1Y
-35.1%
Nxera Pharma
Market Cap: JP¥83.0b
Operates as a biopharmaceutical company, engages in drug discovery and development in Japan, the United States, Germany, Switzerland, Bermuda, the United Kingdom, and internationally.
4565
JP¥896.00
7D
-8.9%
1Y
5.0%
SanBio
Market Cap: JP¥74.2b
Engages in the development, production, and sale of regenerative cell medicines for the central nervous system in Japan and the United States.
4592
JP¥950.00
7D
-6.0%
1Y
-54.3%
Fuji Pharma
Market Cap: JP¥49.0b
Engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally.
4554
JP¥1,875.00
7D
-4.2%
1Y
40.8%
Heartseed
Market Cap: JP¥35.6b
Develops and commercializes iPS cell-derived cardiomyocyte replacement therapy for heart failure.
219A
JP¥1,557.00
7D
-2.1%
1Y
-50.2%
Healios K.K
Market Cap: JP¥32.1b
Engages in the research, development, manufacturing, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States.
4593
JP¥238.00
7D
-7.4%
1Y
-53.1%
StemRIM
Market Cap: JP¥18.9b
A biotechnology company, researches and develops regeneration-inducing medicine in Japan and internationally.
4599
JP¥301.00
7D
-5.3%
1Y
0%
Kidswell Bio
Market Cap: JP¥7.1b
Develops pharmaceutical products for the treatment of pediatric, pediatric, intractable, and Asia-endemic diseases in Japan.
4584
JP¥143.00
7D
-1.4%
1Y
-42.6%
Noile-Immune Biotech
Market Cap: JP¥5.4b
Researches and develops CAR-T cells for novel cancer immunotherapies.
4893
JP¥124.00
7D
0.8%
1Y
-29.1%
TMS
Market Cap: JP¥4.7b
Engages in the research and development, manufacture, and sale of drug products, quasi-drugs, drug substances, medical devices, and medical commodities.
4891
JP¥103.00
7D
-6.4%
1Y
-39.4%